3rd Quarter - Report

ALKERMES, INC. for ALKERMES, INC.

Firm
Client
Income
—
Expenses
$554,400
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

4 issue areas, each in the filer's own words, with who lobbied on it and where.

Alcohol and Drug Abuse ALC

Advance the use of FDA-approved medicines to treat addiction in criminal justice settings H.R.3465/S.1690, The Second Chance Act of 2013 - use of FDA-approved medicines in criminal justice settings S.1675, Recidivism Reduction and Public Safety Act of 2013 - use of FDA-approved medicines in criminal justice settings Comprehensive Addiction Recovery Act of 2014

LobbyistCovered position, as disclosed
ROBERT FORMAN —
PETER NORMAN —

Contacted: HOUSE OF REPRESENTATIVES; Office of Natl Drug Control Policy (NDCP); Natl Institute on Alcohol Abuse & Alcoholism (NIAA); SENATE; Substance Abuse & Mental Health Services Administration (SAMHSA); Justice, Dept of (DOJ); Natl Institutes of Health (NIH)

Bills named: S. 1690 (113th), H.R. 3465 (113th), S. 1675 (113th)

Pharmacy PHA

DEA regulatory transparency in controlled substances scheduling person DEA regulatory transparency in issuing research licenses and quotas H.R.4299,Improving regulatory transparency for new medical therapies act S.2866,Regulatory transparency, patient access, and effective drug enforcement act

LobbyistCovered position, as disclosed
ROBERT FORMAN —
PETER NORMAN —

Contacted: Substance Abuse & Mental Health Services Administration (SAMHSA); Justice, Dept of (DOJ); HOUSE OF REPRESENTATIVES; Office of Natl Drug Control Policy (NDCP); Natl Institutes of Health (NIH); Natl Institute on Alcohol Abuse & Alcoholism (NIAA); SENATE

Bills named: H.R. 4299 (113th), S. 2866 (113th)

Health Issues HCR

Discuss need for educational resources and the use of Vivitrol for public health

LobbyistCovered position, as disclosed
ROBERT FORMAN —
PETER NORMAN —

Contacted: Substance Abuse & Mental Health Services Administration (SAMHSA); HOUSE OF REPRESENTATIVES; Office of Natl Drug Control Policy (NDCP); Natl Institute on Alcohol Abuse & Alcoholism (NIAA); Justice, Dept of (DOJ); Natl Institutes of Health (NIH); SENATE

Medicare/Medicaid MMM

Maintain the program's six protected classes with respect to depression and schizophrenia

LobbyistCovered position, as disclosed
ROBERT FORMAN —
PETER NORMAN —

Contacted: SENATE; Substance Abuse & Mental Health Services Administration (SAMHSA); Office of Natl Drug Control Policy (NDCP); Natl Institute on Alcohol Abuse & Alcoholism (NIAA); HOUSE OF REPRESENTATIVES; Justice, Dept of (DOJ); Natl Institutes of Health (NIH)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.